THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net


S U M M A R Y


DIARY: April 30, 2008 11:38 PM Wednesday; Rod Welch

Millie submits agenda for meeting tomorrow with medical team at UCSF.

1...Summary/Objective
2...Agenda Meeting Evaluate Progress Start Cycle 3 Clinical Trial


..............
Click here to comment!

CONTACTS 

SUBJECTS
Meeting Schedule Agenda Prepare Submit  Panning Medical Team UCSF 08

0803 -
0803 -    ..
0804 - Summary/Objective
0805 -
080501 - Follow up ref SDS 50 0000. ref SDS 49 0000.
080502 -
080503 -
080504 -
080505 -
080506 -
080508 -  ..
0806 -
0807 -
0808 - Progress
0809 -
080901 - Agenda Meeting Evaluate Progress Start Cycle 3 Clinical Trial
080902 -
080903 - Follow up ref SDS 49 659K, ref SDS 48 KX7J.
080904 -
080905 - Millie submitted ref DIT 1 0001 a letter with an agenda guiding the
080906 - meeting tomorrow at UCSF sent to Jackie with copies to the medical
080907 - team, ref DIT 1 00W3, including Gloria at the Kaiser Coagulation
080908 - Control Department for a heads up that a blood test will be submitted.
080910 -  ..
080911 - This follows up Millie's letter to primary care physician on 080428,
080912 - ref SDS 49 659K, expressing thanks for submitting results of the CT
080913 - test on 080425, ref SDS 48 9W9I, and reported at that time on 080428.
080914 - ref SDS 49 6V5I
080915 -
080916 -    1.  Please order blood tests for tomorrow 080501 to start the next
080917 -        cycle in the clinical trial, including CA 15-3 and INR.  The
080918 -        scope of labs is listed in the doctor's record shown on 080313.
080919 -        ref SDS 47 2N6N, ref DIT 1 0001
080921 -         ..
080922 -    2.  The CT test on 080425 was received from Kaiser a few days later
080923 -        on 080428, ref SDS 49 6V5I, and shows stable condition with no
080924 -        evidence of distant metastasis. ref SDS 49 EO8F, ref DIT 1 NQ5G
080926 -         ..
080927 -    3.  Within the past few days there seems to be further and
080928 -        substantial improvement with IBC rash subsiding.    This has
080929 -        occurred with minimal treatments so far (i.e., only 3 of 6 -
080930 -        50% - of prescribed treatments) during the first 2 cycles,
080931 -        demonstrating effectiveness of this protocol.  As stated, no
080932 -        evident side effects have occurred; if anything, I have more
080933 -        energy and vitality now than when I was getting only cetuximab.
080934 -        I am very pleased, and feel more confident about the future.
080935 -        ref DIT 1 NQ5H
080937 -         ..
080938 -    4.  [The primary care physician] at Kaiser is investigating use of
080939 -        a Huber needle to access the port catheter for injecting
080940 -        contrast medium required to perform CT tests, reported on
080941 -        080429. ref SDS 50 1H6Y, ref DIT 1 E178
080943 -         ..
080944 -    5.  I am meeting at Kaiser on Friday about progress on this matter,
080945 -        and would appreciate hearing about experience at UCSF with this
080946 -        method.  Initial research seems promising. ref SDS 50 RE6F
080947 -        ref DIT 1 E18G
080948 -
080949 -           [On 080501 Brigid explained that CT test injections of
080950 -           contrast medium causes higher pressures on the port
080951 -           catheter, and so UCSF began installing only Power Ports
080952 -           designed for higher pressures, ref SDS 51 TQ6F; in some
080953 -           cases UCSF approves using port catheter for injecting CT
080954 -           test contrast medium, and in order to avoid injury, pain,
080955 -           and suffering. ref SDS 51 JJ9N
080957 -            ..
080958 -           [On 080502 primary care physician sent a letter to surgeon
080959 -           at Kaiser investigating follow up surgery to upgrade
080960 -           Millie's port catheter implanted on 040419 to a "Power
080961 -           Port" for injecting CT test contrast medium in order to
080962 -           avoid further injury, pain, and suffering, ref SDS 52 VG5J;
080963 -           there is also consideration of using the existing port
080964 -           catheter by slowing the rate of injecting contrast medium
080965 -           for CT tests (point 2), if that is possible, which reduces
080966 -           risk of damaging the port from high pressure that occurs
080967 -           from CT test injections. ref SDS 52 847I
080968 -
080969 -
080970 -
080971 -
080972 -
080973 -
080974 -
0810 -